Viewing Study NCT01881867


Ignite Creation Date: 2025-12-25 @ 12:45 AM
Ignite Modification Date: 2026-02-24 @ 9:58 AM
Study NCT ID: NCT01881867
Status: COMPLETED
Last Update Posted: 2019-07-09
First Post: 2013-06-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Castration Levels of Testosterone View
None Castration-Resistant Prostate Carcinoma View
None Metastatic Prostate Carcinoma View
None Stage IV Prostate Cancer View
Keywords: